ALLIANCE-A022001-PNETS
Phase II
OPEN TO ACCRUAL
Phase II Randomized, Prospective Trial of Lutetium Lu 177 Dotatate PRRT Versus Capecitabine and Temozolomide in Well-Differentiated Pancreatic Neuroendocrine Tumors
IIT-HALL-SOFT-PRE-OP
Phase II
OPEN TO ACCRUAL
A Randomized, Phase II Clinical Trial of Stereotactic Body Radiation Therapy or Conventionally Fractionated Concurrent Chemotherapy and Radiation Therapy Preoperatively for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
IIT-KAMGAR-PROTECT-PANC
Phase II
OPEN TO ACCRUAL
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer with High-Risk of Cancer Recurrence (PROTECT-PANC)
NRG-GY022
Phase I
OPEN TO ACCRUAL
Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-Sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin